1
Clinical Trials associated with Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization)A Phase I/II Randomized Double Blind Controlled Study to Evaluate the Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Split Virion Influenza Vaccine in Healthy Thai Adults Aged Between 18 Years to 49 Years
The study is aim to evaluate the safety and immunogenicity of one dose (15 μg HA per strain per dose) of the GPO seasonal trivalent inactivated split virion influenza vaccine (Tri Fluvac) in healthy adults aged 18 to 49 years over 90 days post-injection.
100 Clinical Results associated with Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization)
100 Translational Medicine associated with Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization)
100 Patents (Medical) associated with Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization)
100 Deals associated with Seasonal Trivalent Inactivated Split Virion Influenza Vaccine(The Government Pharmaceutical Organization)